Holdings
SR One Capital Management, LP
As of Jun 30, 2026, SR One Capital Management, LP reported 13 positions worth US$919M. Largest: Veradermics, Incorporated, Zenas Biopharma, Inc. and Avalyn Pharma Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Veradermics, Incorporated | 2.4M | US$295M | no change | Jun 30, 2026 |
| Zenas Biopharma, Inc. | 5.04M | US$128M | no change | Jun 30, 2026 |
| Avalyn Pharma Inc. | 3.31M | US$109M | new | Jun 30, 2026 |
| Design Therapeutics, Inc. | 6.53M | US$94.4M | no change | Jun 30, 2026 |
| Odyssey Therapeutics, Inc. | 3.79M | US$71M | new | Jun 30, 2026 |
| Alumis Inc. | 1.96M | US$55.2M | no change | Jun 30, 2026 |
| Oric Pharmaceuticals, Inc. | 4.62M | US$50M | +100K | Jun 30, 2026 |
| Mineralys Therapeutics, Inc. | 1.56M | US$42.2M | no change | Jun 30, 2026 |
| Ars Pharmaceuticals, Inc. | 4.01M | US$32.1M | no change | Jun 30, 2026 |
| Mobia Medical, Inc. | 1.99M | US$26.6M | new | Jun 30, 2026 |